HSBC Holdings’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-95,317
| Closed | -$4.04M | – | 2745 |
|
|
2024
Q1 | $4.04M | Buy |
+95,317
| New | +$4.04M | ﹤0.01% | 960 |
|
|
2021
Q1 | – | Sell |
-11,572
| Closed | -$834K | – | 2660 |
|
|
2020
Q4 | $834K | Buy |
11,572
+715
| +7% | +$51.5K | ﹤0.01% | 1444 |
|
|
2020
Q3 | $596K | Hold |
10,857
| – | – | ﹤0.01% | 1450 |
|
|
2020
Q2 | $722K | Sell |
10,857
-4,563
| -30% | -$303K | ﹤0.01% | 1287 |
|
|
2020
Q1 | $943K | Hold |
15,420
| – | – | ﹤0.01% | 1134 |
|
|
2019
Q4 | $1.37M | Hold |
15,420
| – | – | ﹤0.01% | 1207 |
|
|
2019
Q3 | $1.16M | Sell |
15,420
-14,841
| -49% | -$1.12M | ﹤0.01% | 1337 |
|
|
2019
Q2 | $2.59M | Buy |
30,261
+6,424
| +27% | +$549K | ﹤0.01% | 990 |
|
|
2019
Q1 | $2.58M | Buy |
23,837
+5,384
| +29% | +$582K | ﹤0.01% | 1006 |
|
|
2018
Q4 | $1.56M | Buy |
+18,453
| New | +$1.56M | ﹤0.01% | 1122 |
|
|
2017
Q4 | – | Sell |
-2,737
| Closed | -$308K | – | 1932 |
|
|
2017
Q3 | $308K | Sell |
2,737
-403
| -13% | -$45.4K | ﹤0.01% | 1463 |
|
|
2017
Q2 | $352K | Buy |
3,140
+877
| +39% | +$98.3K | ﹤0.01% | 1369 |
|
|
2017
Q1 | $264K | Sell |
2,263
-256
| -10% | -$29.9K | ﹤0.01% | 1485 |
|
|
2016
Q4 | $265K | Buy |
2,519
+259
| +11% | +$27.2K | ﹤0.01% | 1893 |
|
|
2016
Q3 | $250K | Sell |
2,260
-1,051
| -32% | -$116K | ﹤0.01% | 1444 |
|
|
2016
Q2 | $482K | Buy |
3,311
+1,355
| +69% | +$197K | ﹤0.01% | 1204 |
|
|
2016
Q1 | $280K | Sell |
1,956
-154
| -7% | -$22K | ﹤0.01% | 1436 |
|
|
2015
Q4 | $326K | Buy |
+2,110
| New | +$326K | ﹤0.01% | 1386 |
|